Yong-tao Xu

发表

Carboplatin-based Nanomedicine to Enhance the Anticancer Effect in SK-NEP-1 WilmsꞌTumor Cells

Zhaoxuan Ma, Ming Ming, Yong-tao Xu, 2017, Iranian journal of pharmaceutical research : IJPR.

Design, synthesis, and biological evaluation of novel dual inhibitors targeting lysine specific demethylase 1 (LSD1) and histone deacetylases (HDAC) for treatment of gastric cancer.

Shu-Hui Chen, Yingchao Duan, Yuanyuan Guan, 2021, European journal of medicinal chemistry.

A comprehensive review of BET-targeting PROTACs for cancer therapy.

Yingchao Duan, Yuanyuan Guan, Yong-tao Xu, 2022, Bioorganic & medicinal chemistry.